MaxM, I guess we don't have to worry about where the Pfizer money went as PF has explained that we are taking the Non-cash Assets. This being the case it would seem that in the short term there is going to be further stress on our cash-flow.
This leads me to think that in the next 4-6 weeks we are likely to hear what BLT's financial strategy is going to be.
This deal may also turn out to the the first in a back-to-back deal with a major backer for the TT-034 program (that would certainly have been the smartest play) and we may hear about that (if correct) in the same time frame.
BLT Price at posting:
37.5¢ Sentiment: Hold Disclosure: Held
